Agree To Buy Regeneron Pharmaceuticals At $200, Earn 6% Using Options
July 10, 2014 at 11:54 AM EDT
Investors considering a purchase of Regeneron Pharmaceuticals, Inc. (REGN) shares, but cautious about paying the going market price of $310.28/share, might benefit from considering selling puts among the alternative strategies at their disposal..